Toronto, Canada

Ian Rogers

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mount Sinai Hospital Corporation. Active years: 2009.

USPTO Granted Patents = 1 

 


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian Rogers - Innovator in Cellular Compositions

Introduction

Ian Rogers is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cellular compositions, particularly in the area of hematopoietic cells. His work focuses on the potential of these cells to form non-hematopoietic cells, which has important implications for medical research and treatment.

Latest Patents

Ian Rogers holds a patent for "Cellular compositions and methods of making and using them." This invention relates to cellular compositions comprising hematopoietic cells with the potential or increased potential to form non-hematopoietic cells. The patent outlines methods for producing such cellular compositions, as well as methods for differentiating cells of these compositions into cells that exhibit various features of non-hematopoietic cells. Additionally, the invention includes a method for the expansion of hematopoietic stem and progenitor cells. He has 1 patent to his name.

Career Highlights

Ian Rogers is affiliated with Mount Sinai Hospital Corporation, where he applies his expertise in cellular research. His work at this institution has allowed him to contribute to advancements in medical science and patient care.

Collaborations

Ian collaborates with Robert Frederic Casper, a fellow researcher, to further explore the potential of cellular compositions and their applications in medicine.

Conclusion

Ian Rogers is a pioneering inventor whose work in cellular compositions has the potential to impact various fields, particularly in regenerative medicine. His contributions continue to advance our understanding of hematopoietic cells and their applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…